Citation 61381

UMEZAWA,H: IMOTO,M: SAWA,T: ISSHIKI,K: MATSUDA,N: UCHIDA,T: IINUMA,H: HAMADA,M: TAKEUCHI,T:. (1986). STUDIES ON A NEW EPIDERMAL GROWTH FACTOR-RECEPTOR KINASE INHIBITOR, ERBSTATIN, PRODUCED BY MH435-HF3.. 39(1)

Citation Details

Title	STUDIES ON A NEW EPIDERMAL GROWTH FACTOR-RECEPTOR KINASE INHIBITOR, ERBSTATIN, PRODUCED BY MH435-HF3.
Authors	UMEZAWA,H: IMOTO,M: SAWA,T: ISSHIKI,K: MATSUDA,N: UCHIDA,T: IINUMA,H: HAMADA,M: TAKEUCHI,T:
Year	1986
Volume	39
Issue	1

Summary

Year: 1986

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces species (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ERBSTATIN	None
2	PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERBSTATIN	None
3	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERBSTATIN	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERBSTATIN	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERBSTATIN	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ERBSTATIN	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERBSTATIN	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERBSTATIN	ACTIVE
9	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	ERBSTATIN	.

Show SPARQL Queries (1)